70 results
PRE 14A
AXLA
Axcella Health Inc.
7 Aug 23
Preliminary proxy
4:15pm
held positions of increasing responsibility at Pfizer, with his last position as Vice President, heading up Pfizer’s Worldwide R&D Strategic … of increasing responsibility at MedImmune, LLC, a wholly owned subsidiary of AstraZeneca, most recently as Senior Vice President R&D, Head
8-K
euxywwedbui3im6l30j
13 Oct 22
Entry into a Material Definitive Agreement
8:15am
8-K
EX-10.1
7x8go8790b554 zz
13 Oct 22
Entry into a Material Definitive Agreement
8:15am
424B5
fv0fz85w0nl4wme56ch1
13 Oct 22
Prospectus supplement for primary offering
7:55am
8-K
EX-10.1
jnc2q
23 Sep 22
Entry into a Material Definitive Agreement
4:01pm
8-K
EX-10.1
q19mztvx if62
16 Mar 22
Axcella Therapeutics Announces $25 Million Registered Direct Offering of Common Stock Priced At the Market
8:30am
424B5
wg2w36r
16 Mar 22
Prospectus supplement for primary offering
8:00am
8-K
EX-10.1
k1b7azen5 82ftdm
7 Feb 22
Axcella Therapeutics Announces Appointment of New Chief Financial Officer
4:00pm
8-K
jqp8qqg
7 Dec 21
Departure of Directors or Certain Officers
6:15am
8-K
EX-10.1
cuxyzonym5vvqt551r
7 Dec 21
Departure of Directors or Certain Officers
6:15am